Experts question lack of clinical data to support FDA decision on monoclonal antibody treatments - TheBlaze

Experts question lack of clinical data to support FDA decision on monoclonal antibody treatments - TheBlaze: 

"In Florida, we saw over a 90 percent reduction in total hospitalizations within a few months of implementing monoclonal antibody treatment, due in part both to the peak of our seasonal summer wave and also the success of over 4,000 new mAbs patients a day in our statewide treatment locations," Lamb said.